Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines.
A new study appearing in Nature Medicine points to a simple blood test that can predict who is at risk of developing Alzheimer’s disease before the symptoms of the disease appear. With this new tool, scientists may be able to develop a new generation of therapies that can head off the disease.
Rochester researchers found that a high dose of a common antidepressant drug (citalopram) significantly reduced agitation in Alzheimer’s patients. Agitation is one of the most common reasons Alzheimer’s patients are moved out of their homes into higher levels of care.
Why do we sleep? It is a question that has long puzzled scientists and philosophers alike. While the ancient Greeks saw sleep as a doorway to the divine, scientists and biologists see it as an invitation to be devoured by nocturnal predators. A new study – appearing today in the journal Science – may provide the answer: when we sleep our brain ‘takes out the trash.’
Copper is ubiquitous in the food supply and drinking water. In the right amounts, it helps the body perform many important functions. However, a new study points to the metal’s darker side: too much copper can accumulate in the brain and contribute to the buildup of toxic proteins that cause Alzheimer’s disease.
The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.
April 2014 (4)
March 2014 (8)
February 2014 (11)
January 2014 (6)
December 2013 (10)
November 2013 (5)
October 2013 (8)
September 2013 (7)
August 2013 (12)
July 2013 (12)
June 2013 (14)
May 2013 (2)